- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.39 BnMarket Estimate, 2026
$0.43 BnMarket Forecast, 2034
$0.97 BnCAGR, 2026–2034
10.77%Executive Summary: Middle East and Africa Pen Needles Market
- Market Scope: Comprehensive regional analysis of the Middle East and Africa pen needles sector detailing therapy types, needle configurations, safety mechanisms, purchasing modes, healthcare infrastructure challenges, and country-level profiles.
- Market Valuation: Valued at USD 0.39 billion in 2025, reaching USD 0.43 billion in 2026, and projected to expand to USD 0.97 billion by 2034, growing at a robust CAGR of 10.77% from 2026 to 2034.
- Primary Growth Drivers: Growing annual healthcare expenditure, increasing public and private initiatives in diabetes awareness programs, and rising demand for advanced insulin delivery devices.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Therapy | Insulin Therapy (held dominant share, driven by high chronic disease management demands) | GLP-1 Therapy (projected at high growth, fueled by rising metabolic treatments and obesity care) |
| By Type | Standard Needle (accounted for major share, anchored by cost-sensitivity and widespread consumer adoption) | Safety Needle (expanding rapidly, driven by institutional safety standards and injury prevention) |
| By Needle Length | 4mm (held leading share, supported by clinical recommendations for reduced tissue trauma and pain) | 6mm (fastest-growing length variant, balancing effective subcutaneous delivery across diverse patient BMI profiles) |
| By Mode of Purchase | Retail (dominated market share, backed by local pharmacy chains and direct consumer access) | Non-Retail (projected at high growth, propelled by home healthcare expansion and institutional distribution) |
| By Country | KSA / Saudi Arabia (market leader backed by robust healthcare investments and Vision initiatives) | UAE & South Africa (key high-growth hubs driven by medical tourism and advanced diabetes care adoption) |
Major Market Players & Industry Landscape
Market Structure: Highly consolidated and competitive landscape featuring dominant international medical device manufacturers and global leaders focusing on product accessibility, distribution networks, and advanced needle solutions.
Key Companies: Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, B. Braun Melsungen AG, and Terumo Corporation.
Download Free Sample Report
Middle East and Africa Pen Needles Market Size
The Middle East and Africa pen needles market size was valued at USD 0.39 billion in 2025 and is anticipated to reach USD 0.43 billion in 2026 from USD 0.97 billion by 2034, growing at a CAGR of 10.77% during the forecast period from 2026 to 2034.
Pen needles are used to deliver the medication (such as insulin or other injectable medications) combined with injection pens. A pen needle comprises a hollow needle attached to an injection pen. Pen needles are available with varied needle lengths and are mainly utilized by diabetes patients.
Growing annual health care expenditure, increasing public & private organizations' involvement in diabetes awareness programs, and rising demand for advanced insulin delivery devices drive the growth of the Middle East & Africa pen needles market. However, limited accessibility of pen needles and lack of health care infrastructure & outdated facilities are restraining the growth of the Middle East & Africa pen needles market.
KEY MARKET PLAYERS
Companies leading the MEA Pen Needles Market include
- Becton, Dickinson and Company (U.S.)
- Novo Nordisk A/S (Denmark)
- Ypsomed Holding AG (Switzerland)
- UltiMed, Inc. (U.S.)
- Allison Medical, Inc. (U.S.)
- Owen Mumford, Ltd. (U.K.)
- B. Braun Melsungen AG (Germany)
- Artsana S.p.A. (Italy)
- HTL-STREFA S.A. (Poland)
- Terumo Corporation (Japan)
- Others
MARKET SEGMENTATION
This research report on the Middle East and Africa Pen Needles Market has been segmented and sub-segmented into the following categories
By Therapy
- Insulin Therapy
- GLP-1 Therapy
- Growth Hormone Therapy
By Type
- Standard Needle
- Safety Needle
By Needle Length
- 4mm
- 6mm
- 8mm
- 10mm
- 12mm
By Mode of Purchase
- Retail
- Non-Retail
By Country
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA